id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2026-N-0958-0001,FDA,FDA-2026-N-0958,Issuance of Priority Review Voucher; Rare Pediatric Disease Product; ZEVASKYN (Prademagene Zamikeracel),Notice,Announcement,2026-02-18T05:00:00Z,2026,2,,,2026-02-18T19:14:39Z,2026-03211,0,0,09000064b91b8ec7